Skip to main content

JP Morgan Raises PT On CVS To $43

Joe Young

May 31, 2011 6:41am Comments

JP Morgan has raised the price target on CVS Caremark Corporation (NYSE: CVS) from $42 to $43 and maintains its Overweight rating.

© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

View Comments and Join the Discussion!

View the discussion thread.

Posted-In: CVS Caremark Corporation JP Morgan Price Target Analyst Ratings

Need analyst data?
Click here to see licensing options.

Latest Ratings

View the Latest Analytics Ratings

1	WRD, PONY: Pony AI Vs. WeRide: Who's Leading China's Robotaxi Race
2	CMG: Stock Of The Day: Time To Buy Chipotle Mexican Grill?
3	TM, STLA: Trump Tariff Worries Drive Middle-Income Americans To Rush C...
4	The Secret To Profitable Trading That No One Wants To Hear
5	UBER, LCID: Consumer Tech News (July 21–July 25): Big Tech E...
6	EPD, CRI: S&P 500 Notches 5th Consecutive Record...
7	Trump's Charm Offense In Europe Unlea...

1	IVES, BRK: Wall Street's Star Tracker ETFs Are Booming—But Copying Warren B...
2	Trump's EU Trade Deal An Act Of 'Submission,' Says Frenc...
3	PG, BA: Boeing, Procter & Gamble And 3 Stocks To Watch Heading Into T...
4	MSFT, NVDA: Nvidia Tops $4.3 Trillion Valuation, Surpassing Microso...
5	BA: Boeing 777-9 Inches Closer To Takeoff After FAA Go-Ah...
6	BABA, NVDA: Nvidia Orders Another 300,000 H20 Chips Fro...
7	GOOGL, META: Apple's iOS 26 Sparks GOP P...